It has also been recently shown for cells of several types of cancer (glioma, pancreatic cancer, and stomach cancer) that the elevated expression of SOX9 leads to a decrease in CDKN1A and to the stimulation of cell division [45]. Here, SOX9 is linked to central nervous system cancer.